Clinical Trial Update: Different Fluorescein Sodium Dosage for the Detection of Gastric Intestinal Metaplasia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from Shandong University is evaluating different fluorescein sodium dosages for detecting gastric intestinal metaplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Intestinal Metaplasia

Drugs mentioned

• Fluorescein Sodium (fluorescein sodium)

Snippet

Sponsor: Shandong University | Conditions: Gastric Intestinal Metaplasia | Phase 4 | Status: UNKNOWN